Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis

Background A female/male (F/M) ratio increase over time in multiple sclerosis (MS) patients was demonstrated in many countries around the world. So far, a direct comparison of sex ratio time-trends among MS populations from different geographical areas was not carried out. Objective In this paper we assessed and compared sex ratio trends, over a 60-year span, in MS populations belonging to different latitudinal areas. Methods Data of a cohort of 15,996 (F = 11,290; M = 4,706) definite MS with birth years ranging from 1930 to 1989 were extracted from the international MSBase registry and the New Zealand MS database. Gender ratios were calculated by six decades based on year of birth and were adjusted for the F/M born-alive ratio derived from the respective national registries of births. Results Adjusted sex ratios showed a significant increase from the first to the last decade in the whole MS sample (from 2.35 to 2.73; p = 0.03) and in the subgroups belonging to the areas between 83° N and 45° N (from 1.93 to 4.55; p<0.0001) and between 45° N to 35° N (from 1.46 to 2.30; p<0.05) latitude, while a sex ratio stability over time was found in the subgroup from areas between 12° S and 55° S latitude. The sex ratio increase mainly affected relapsing-remitting (RR) MS. Conclusions Our results confirm a general sex ratio increase over time in RRMS and also demonstrate a latitudinal gradient of this increase. These findings add useful information for planning case-control studies aimed to explore sex-related factors responsible for MS development.

[1]  A. Sadovnick,et al.  Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study , 2009, Journal of Neurology, Neurosurgery & Psychiatry.

[2]  G. Giovannoni,et al.  Smoking and Multiple Sclerosis: An Updated Meta-Analysis , 2011, PloS one.

[3]  Yinshan Zhao,et al.  Relative mortality and survival in multiple sclerosis: findings from British Columbia, Canada , 2011, Journal of Neurology, Neurosurgery & Psychiatry.

[4]  T. Olsson,et al.  Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. , 2011, Brain : a journal of neurology.

[5]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[6]  A. Minagar,et al.  Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study , 2010, Multiple sclerosis.

[7]  E. Celius,et al.  Change in sex ratio, disease course and age at diagnosis in Oslo MS patients through seven decades , 2009, Acta neurologica Scandinavica. Supplementum.

[8]  C. Poser Prevalence of multiple sclerosis , 1992, Annals of neurology.

[9]  R. Marrie,et al.  Changes in the ascertainment of multiple sclerosis , 2005, Neurology.

[10]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[11]  Y. Itoyama,et al.  Temporal changes and geographical differences in multiple sclerosis phenotypes in Japanese: nationwide survey results over 30 years , 2009, Multiple sclerosis.

[12]  L. Wald,et al.  Association of UV radiation with multiple sclerosis prevalence and sex ratio in France , 2011, Neurology.

[13]  C. Massilamany,et al.  Gender differences in CNS autoimmunity induced by mimicry epitope for PLP 139–151 in SJL mice , 2011, Journal of Neuroimmunology.

[14]  M. Schumacher,et al.  Hormonal influences in multiple sclerosis: new therapeutic benefits for steroids. , 2011, Maturitas.

[15]  G. Giovannoni,et al.  An Updated Meta-Analysis of Risk of Multiple Sclerosis following Infectious Mononucleosis , 2010, PloS one.

[16]  L. Kappos,et al.  MSBase: an international, online registry and platform for collaborative outcomes research in multiple sclerosis , 2006, Multiple sclerosis.

[17]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.

[18]  T. Riise,et al.  Long-term follow-up of benign multiple sclerosis in Hordaland County, Western Norway , 2009, Multiple sclerosis.

[19]  M. Horsburgh,et al.  AUCKLAND DISTRICT HEALTH BOARD , 2003 .

[20]  Jeffrey A. Cohen,et al.  Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria , 2011, Annals of neurology.

[21]  B. Hemmer,et al.  The increasing incidence and prevalence of female multiple sclerosis--a critical analysis of potential environmental factors. , 2011, Autoimmunity reviews.

[22]  S. Reingold,et al.  Diagnostic criteria for multiple sclerosis: 2005 revisions to the “McDonald Criteria” , 2005, Annals of neurology.

[23]  P. Sørensen,et al.  The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.

[24]  H. Brønnum-Hansen,et al.  Prevalence of multiple sclerosis in Denmark 1950—2005 , 2010, Multiple sclerosis.

[25]  E. Willoughby,et al.  MS prevalence in New Zealand, an ethnically and latitudinally diverse country , 2010, Multiple sclerosis.

[26]  A. Ponsonby,et al.  Trends in the epidemiology of multiple sclerosis in Greater Hobart, Tasmania: 1951 to 2009 , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[27]  T. Dwyer,et al.  Higher 25‐hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis , 2010, Annals of neurology.

[28]  M. Amini,et al.  Prevalence of Vitamin D Deficiency in Isfahani High School Students in 2004 , 2005, Hormone Research in Paediatrics.

[29]  Barrie J Hurwitz,et al.  Registry studies of long-term multiple sclerosis outcomes , 2011, Neurology.

[30]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[31]  F. Guillemin,et al.  Increasing incidence of multiple sclerosis among women in Lorraine, Eastern France , 2007, Multiple sclerosis.

[32]  Justin A. Spanier,et al.  Estrogen Controls Vitamin D3-Mediated Resistance to Experimental Autoimmune Encephalomyelitis by Controlling Vitamin D3 Metabolism and Receptor Expression1 , 2009, The Journal of Immunology.

[33]  J. Salzer Environmental risk factors for multiple sclerosis , 2013 .

[34]  W. James Gauderman,et al.  Childhood sun exposure influences risk of multiple sclerosis in monozygotic twins , 2007, Neurology.

[35]  M. Sahraian,et al.  Multiple Sclerosis in Iran: A Demographic Study of 8,000 Patients and Changes over Time , 2010, European Neurology.

[36]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[37]  A. Ascherio,et al.  Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence. , 2011, Annals of Epidemiology.

[38]  J. Correale,et al.  Immunomodulatory effects of Vitamin D in multiple sclerosis. , 2009, Brain : a journal of neurology.

[39]  A. Sadovnick,et al.  MHC transmission , 2011, Neurology.

[40]  C. Polman,et al.  Higher levels of 25-hydroxyvitamin D are associated with a lower incidence of multiple sclerosis only in women , 2009, Multiple sclerosis.

[41]  T. Sarpel,et al.  Vitamin D status and bone mineral density of veiled and unveiled Turkish women. , 2001, Journal of women's health & gender-based medicine.

[42]  J. Byrnes,et al.  Sex ratio of multiple sclerosis and clinical phenotype , 2010, European journal of neurology.

[43]  J. Correale,et al.  Gender Differences in 1,25 Dihydroxyvitamin D3 Immunomodulatory Effects in Multiple Sclerosis Patients and Healthy Subjects , 2010, The Journal of Immunology.

[44]  A. Ascherio,et al.  Environmental risk factors for multiple sclerosis. Part II: Noninfectious factors , 2007, Annals of neurology.

[45]  J. Knight,et al.  Expression of the Multiple Sclerosis-Associated MHC Class II Allele HLA-DRB1*1501 Is Regulated by Vitamin D , 2009, PLoS genetics.

[46]  G. Ebers,et al.  Relationship of UV exposure to prevalence of multiple sclerosis in England , 2011, Neurology.

[47]  A. Sadovnick,et al.  European Charcot Foundation Lecture: The natural history of multiple sclerosis and gender , 2009, Journal of the Neurological Sciences.

[48]  C. Bever,et al.  Sun Exposure, Vitamin D and Age at Disease Onset in Relapsing Multiple Sclerosis , 2010, Neuroepidemiology.

[49]  M. Hernán,et al.  Temporal trends in the incidence of multiple sclerosis , 2008, Neurology.